PCV81 - COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN FOR HIGH-RISK PATIENTS WITH ESTABLISHED PERIPHERAL ARTERIAL DISEASE IN CHINA

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.627
https://www.valueinhealthjournal.com/article/S1098-3015(18)33927-5/fulltext
Section Title :
Section Order : 44
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33927-5&doi=10.1016/j.jval.2018.09.627
HEOR Topics :
Tags :
Regions :